0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Colorectal Cancer Molecular Diagnostics Kit Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-28N13027
Home | Market Reports | Health| Medical Facilities & Services| Medical Procedures
Global Colorectal Cancer Molecular Diagnostics Kit Market Research Report 2023
BUY CHAPTERS

Global Colorectal Cancer Molecular Diagnostics Kit Market Research Report 2025

Code: QYRE-Auto-28N13027
Report
May 2025
Pages:78
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Colorectal Cancer Molecular Diagnostics Kit Market Size

The global market for Colorectal Cancer Molecular Diagnostics Kit was valued at US$ 877 million in the year 2024 and is projected to reach a revised size of US$ 2195 million by 2031, growing at a CAGR of 14.2% during the forecast period.

Colorectal Cancer Molecular Diagnostics Kit Market

Colorectal Cancer Molecular Diagnostics Kit Market

The main techniques involved in molecular testing for CRC are PCR based methods, DNA sequencing and immunohistochemistry analysis of tissue sections. These methods are currently used for diagnosis of Lynch syndrome by detection of MSI phenotype and discriminating them from sporadic CRC by looking for BRAF mutation.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Colorectal Cancer Molecular Diagnostics Kit, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Colorectal Cancer Molecular Diagnostics Kit.
The Colorectal Cancer Molecular Diagnostics Kit market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Colorectal Cancer Molecular Diagnostics Kit market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Colorectal Cancer Molecular Diagnostics Kit companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Colorectal Cancer Molecular Diagnostics Kit Market Report

Report Metric Details
Report Name Colorectal Cancer Molecular Diagnostics Kit Market
Accounted market size in year US$ 877 million
Forecasted market size in 2031 US$ 2195 million
CAGR 14.2%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Hospital
  • Third-party Testing Agency
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Roche, Abbott, Thermo Fisher, Kej, Illumina, Bio Mérieux, Bio-Rad Life Medicine, Agilent, Daan Gene, Ed Bio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Colorectal Cancer Molecular Diagnostics Kit company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Colorectal Cancer Molecular Diagnostics Kit Market growing?

Ans: The Colorectal Cancer Molecular Diagnostics Kit Market witnessing a CAGR of 14.2% during the forecast period 2025-2031.

What is the Colorectal Cancer Molecular Diagnostics Kit Market size in 2031?

Ans: The Colorectal Cancer Molecular Diagnostics Kit Market size in 2031 will be US$ 2195 million.

Who are the main players in the Colorectal Cancer Molecular Diagnostics Kit Market report?

Ans: The main players in the Colorectal Cancer Molecular Diagnostics Kit Market are Roche, Abbott, Thermo Fisher, Kej, Illumina, Bio Mérieux, Bio-Rad Life Medicine, Agilent, Daan Gene, Ed Bio

What are the Application segmentation covered in the Colorectal Cancer Molecular Diagnostics Kit Market report?

Ans: The Applications covered in the Colorectal Cancer Molecular Diagnostics Kit Market report are Hospital, Third-party Testing Agency, Other

What are the Type segmentation covered in the Colorectal Cancer Molecular Diagnostics Kit Market report?

Ans: The Types covered in the Colorectal Cancer Molecular Diagnostics Kit Market report are PCR, Molecular Hybridization, Biochip, Other

Recommended Reports

Cancer Diagnostics Kits

Molecular Cancer Diagnostics

Molecular Diagnostic Products

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Molecular Diagnostics Kit Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 PCR
1.2.3 Molecular Hybridization
1.2.4 Biochip
1.2.5 Other
1.3 Market by Application
1.3.1 Global Colorectal Cancer Molecular Diagnostics Kit Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Third-party Testing Agency
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Molecular Diagnostics Kit Market Perspective (2020-2031)
2.2 Global Colorectal Cancer Molecular Diagnostics Kit Growth Trends by Region
2.2.1 Global Colorectal Cancer Molecular Diagnostics Kit Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Colorectal Cancer Molecular Diagnostics Kit Historic Market Size by Region (2020-2025)
2.2.3 Colorectal Cancer Molecular Diagnostics Kit Forecasted Market Size by Region (2026-2031)
2.3 Colorectal Cancer Molecular Diagnostics Kit Market Dynamics
2.3.1 Colorectal Cancer Molecular Diagnostics Kit Industry Trends
2.3.2 Colorectal Cancer Molecular Diagnostics Kit Market Drivers
2.3.3 Colorectal Cancer Molecular Diagnostics Kit Market Challenges
2.3.4 Colorectal Cancer Molecular Diagnostics Kit Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Molecular Diagnostics Kit Players by Revenue
3.1.1 Global Top Colorectal Cancer Molecular Diagnostics Kit Players by Revenue (2020-2025)
3.1.2 Global Colorectal Cancer Molecular Diagnostics Kit Revenue Market Share by Players (2020-2025)
3.2 Global Colorectal Cancer Molecular Diagnostics Kit Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Colorectal Cancer Molecular Diagnostics Kit Revenue
3.4 Global Colorectal Cancer Molecular Diagnostics Kit Market Concentration Ratio
3.4.1 Global Colorectal Cancer Molecular Diagnostics Kit Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Molecular Diagnostics Kit Revenue in 2024
3.5 Global Key Players of Colorectal Cancer Molecular Diagnostics Kit Head office and Area Served
3.6 Global Key Players of Colorectal Cancer Molecular Diagnostics Kit, Product and Application
3.7 Global Key Players of Colorectal Cancer Molecular Diagnostics Kit, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Molecular Diagnostics Kit Breakdown Data by Type
4.1 Global Colorectal Cancer Molecular Diagnostics Kit Historic Market Size by Type (2020-2025)
4.2 Global Colorectal Cancer Molecular Diagnostics Kit Forecasted Market Size by Type (2026-2031)
5 Colorectal Cancer Molecular Diagnostics Kit Breakdown Data by Application
5.1 Global Colorectal Cancer Molecular Diagnostics Kit Historic Market Size by Application (2020-2025)
5.2 Global Colorectal Cancer Molecular Diagnostics Kit Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Colorectal Cancer Molecular Diagnostics Kit Market Size (2020-2031)
6.2 North America Colorectal Cancer Molecular Diagnostics Kit Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2020-2025)
6.4 North America Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Colorectal Cancer Molecular Diagnostics Kit Market Size (2020-2031)
7.2 Europe Colorectal Cancer Molecular Diagnostics Kit Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2020-2025)
7.4 Europe Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Market Size (2020-2031)
8.2 Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Market Size by Region (2020-2025)
8.4 Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Molecular Diagnostics Kit Market Size (2020-2031)
9.2 Latin America Colorectal Cancer Molecular Diagnostics Kit Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2020-2025)
9.4 Latin America Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Market Size (2020-2031)
10.2 Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2020-2025)
10.4 Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Roche
11.1.1 Roche Company Details
11.1.2 Roche Business Overview
11.1.3 Roche Colorectal Cancer Molecular Diagnostics Kit Introduction
11.1.4 Roche Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
11.1.5 Roche Recent Development
11.2 Abbott
11.2.1 Abbott Company Details
11.2.2 Abbott Business Overview
11.2.3 Abbott Colorectal Cancer Molecular Diagnostics Kit Introduction
11.2.4 Abbott Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
11.2.5 Abbott Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Details
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher Colorectal Cancer Molecular Diagnostics Kit Introduction
11.3.4 Thermo Fisher Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
11.3.5 Thermo Fisher Recent Development
11.4 Kej
11.4.1 Kej Company Details
11.4.2 Kej Business Overview
11.4.3 Kej Colorectal Cancer Molecular Diagnostics Kit Introduction
11.4.4 Kej Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
11.4.5 Kej Recent Development
11.5 Illumina
11.5.1 Illumina Company Details
11.5.2 Illumina Business Overview
11.5.3 Illumina Colorectal Cancer Molecular Diagnostics Kit Introduction
11.5.4 Illumina Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
11.5.5 Illumina Recent Development
11.6 Bio Mérieux
11.6.1 Bio Mérieux Company Details
11.6.2 Bio Mérieux Business Overview
11.6.3 Bio Mérieux Colorectal Cancer Molecular Diagnostics Kit Introduction
11.6.4 Bio Mérieux Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
11.6.5 Bio Mérieux Recent Development
11.7 Bio-Rad Life Medicine
11.7.1 Bio-Rad Life Medicine Company Details
11.7.2 Bio-Rad Life Medicine Business Overview
11.7.3 Bio-Rad Life Medicine Colorectal Cancer Molecular Diagnostics Kit Introduction
11.7.4 Bio-Rad Life Medicine Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
11.7.5 Bio-Rad Life Medicine Recent Development
11.8 Agilent
11.8.1 Agilent Company Details
11.8.2 Agilent Business Overview
11.8.3 Agilent Colorectal Cancer Molecular Diagnostics Kit Introduction
11.8.4 Agilent Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
11.8.5 Agilent Recent Development
11.9 Daan Gene
11.9.1 Daan Gene Company Details
11.9.2 Daan Gene Business Overview
11.9.3 Daan Gene Colorectal Cancer Molecular Diagnostics Kit Introduction
11.9.4 Daan Gene Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
11.9.5 Daan Gene Recent Development
11.10 Ed Bio
11.10.1 Ed Bio Company Details
11.10.2 Ed Bio Business Overview
11.10.3 Ed Bio Colorectal Cancer Molecular Diagnostics Kit Introduction
11.10.4 Ed Bio Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
11.10.5 Ed Bio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Colorectal Cancer Molecular Diagnostics Kit Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of PCR
 Table 3. Key Players of Molecular Hybridization
 Table 4. Key Players of Biochip
 Table 5. Key Players of Other
 Table 6. Global Colorectal Cancer Molecular Diagnostics Kit Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Colorectal Cancer Molecular Diagnostics Kit Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Colorectal Cancer Molecular Diagnostics Kit Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Colorectal Cancer Molecular Diagnostics Kit Market Share by Region (2020-2025)
 Table 10. Global Colorectal Cancer Molecular Diagnostics Kit Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Colorectal Cancer Molecular Diagnostics Kit Market Share by Region (2026-2031)
 Table 12. Colorectal Cancer Molecular Diagnostics Kit Market Trends
 Table 13. Colorectal Cancer Molecular Diagnostics Kit Market Drivers
 Table 14. Colorectal Cancer Molecular Diagnostics Kit Market Challenges
 Table 15. Colorectal Cancer Molecular Diagnostics Kit Market Restraints
 Table 16. Global Colorectal Cancer Molecular Diagnostics Kit Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Colorectal Cancer Molecular Diagnostics Kit Market Share by Players (2020-2025)
 Table 18. Global Top Colorectal Cancer Molecular Diagnostics Kit Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Molecular Diagnostics Kit as of 2024)
 Table 19. Ranking of Global Top Colorectal Cancer Molecular Diagnostics Kit Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Colorectal Cancer Molecular Diagnostics Kit Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Colorectal Cancer Molecular Diagnostics Kit, Headquarters and Area Served
 Table 22. Global Key Players of Colorectal Cancer Molecular Diagnostics Kit, Product and Application
 Table 23. Global Key Players of Colorectal Cancer Molecular Diagnostics Kit, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Colorectal Cancer Molecular Diagnostics Kit Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Colorectal Cancer Molecular Diagnostics Kit Revenue Market Share by Type (2020-2025)
 Table 27. Global Colorectal Cancer Molecular Diagnostics Kit Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Colorectal Cancer Molecular Diagnostics Kit Revenue Market Share by Type (2026-2031)
 Table 29. Global Colorectal Cancer Molecular Diagnostics Kit Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Colorectal Cancer Molecular Diagnostics Kit Revenue Market Share by Application (2020-2025)
 Table 31. Global Colorectal Cancer Molecular Diagnostics Kit Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Colorectal Cancer Molecular Diagnostics Kit Revenue Market Share by Application (2026-2031)
 Table 33. North America Colorectal Cancer Molecular Diagnostics Kit Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Colorectal Cancer Molecular Diagnostics Kit Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Colorectal Cancer Molecular Diagnostics Kit Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Roche Company Details
 Table 49. Roche Business Overview
 Table 50. Roche Colorectal Cancer Molecular Diagnostics Kit Product
 Table 51. Roche Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025) & (US$ Million)
 Table 52. Roche Recent Development
 Table 53. Abbott Company Details
 Table 54. Abbott Business Overview
 Table 55. Abbott Colorectal Cancer Molecular Diagnostics Kit Product
 Table 56. Abbott Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025) & (US$ Million)
 Table 57. Abbott Recent Development
 Table 58. Thermo Fisher Company Details
 Table 59. Thermo Fisher Business Overview
 Table 60. Thermo Fisher Colorectal Cancer Molecular Diagnostics Kit Product
 Table 61. Thermo Fisher Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025) & (US$ Million)
 Table 62. Thermo Fisher Recent Development
 Table 63. Kej Company Details
 Table 64. Kej Business Overview
 Table 65. Kej Colorectal Cancer Molecular Diagnostics Kit Product
 Table 66. Kej Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025) & (US$ Million)
 Table 67. Kej Recent Development
 Table 68. Illumina Company Details
 Table 69. Illumina Business Overview
 Table 70. Illumina Colorectal Cancer Molecular Diagnostics Kit Product
 Table 71. Illumina Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025) & (US$ Million)
 Table 72. Illumina Recent Development
 Table 73. Bio Mérieux Company Details
 Table 74. Bio Mérieux Business Overview
 Table 75. Bio Mérieux Colorectal Cancer Molecular Diagnostics Kit Product
 Table 76. Bio Mérieux Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025) & (US$ Million)
 Table 77. Bio Mérieux Recent Development
 Table 78. Bio-Rad Life Medicine Company Details
 Table 79. Bio-Rad Life Medicine Business Overview
 Table 80. Bio-Rad Life Medicine Colorectal Cancer Molecular Diagnostics Kit Product
 Table 81. Bio-Rad Life Medicine Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025) & (US$ Million)
 Table 82. Bio-Rad Life Medicine Recent Development
 Table 83. Agilent Company Details
 Table 84. Agilent Business Overview
 Table 85. Agilent Colorectal Cancer Molecular Diagnostics Kit Product
 Table 86. Agilent Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025) & (US$ Million)
 Table 87. Agilent Recent Development
 Table 88. Daan Gene Company Details
 Table 89. Daan Gene Business Overview
 Table 90. Daan Gene Colorectal Cancer Molecular Diagnostics Kit Product
 Table 91. Daan Gene Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025) & (US$ Million)
 Table 92. Daan Gene Recent Development
 Table 93. Ed Bio Company Details
 Table 94. Ed Bio Business Overview
 Table 95. Ed Bio Colorectal Cancer Molecular Diagnostics Kit Product
 Table 96. Ed Bio Revenue in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025) & (US$ Million)
 Table 97. Ed Bio Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Colorectal Cancer Molecular Diagnostics Kit Picture
 Figure 2. Global Colorectal Cancer Molecular Diagnostics Kit Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Colorectal Cancer Molecular Diagnostics Kit Market Share by Type: 2024 VS 2031
 Figure 4. PCR Features
 Figure 5. Molecular Hybridization Features
 Figure 6. Biochip Features
 Figure 7. Other Features
 Figure 8. Global Colorectal Cancer Molecular Diagnostics Kit Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Colorectal Cancer Molecular Diagnostics Kit Market Share by Application: 2024 VS 2031
 Figure 10. Hospital Case Studies
 Figure 11. Third-party Testing Agency Case Studies
 Figure 12. Other Case Studies
 Figure 13. Colorectal Cancer Molecular Diagnostics Kit Report Years Considered
 Figure 14. Global Colorectal Cancer Molecular Diagnostics Kit Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Colorectal Cancer Molecular Diagnostics Kit Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Colorectal Cancer Molecular Diagnostics Kit Market Share by Region: 2024 VS 2031
 Figure 17. Global Colorectal Cancer Molecular Diagnostics Kit Market Share by Players in 2024
 Figure 18. Global Top Colorectal Cancer Molecular Diagnostics Kit Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Molecular Diagnostics Kit as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Colorectal Cancer Molecular Diagnostics Kit Revenue in 2024
 Figure 20. North America Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Colorectal Cancer Molecular Diagnostics Kit Market Share by Country (2020-2031)
 Figure 22. United States Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Colorectal Cancer Molecular Diagnostics Kit Market Share by Country (2020-2031)
 Figure 26. Germany Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Colorectal Cancer Molecular Diagnostics Kit Market Share by Region (2020-2031)
 Figure 34. China Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Colorectal Cancer Molecular Diagnostics Kit Market Share by Country (2020-2031)
 Figure 42. Mexico Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Colorectal Cancer Molecular Diagnostics Kit Market Share by Country (2020-2031)
 Figure 46. Turkey Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Colorectal Cancer Molecular Diagnostics Kit Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Roche Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
 Figure 50. Abbott Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
 Figure 51. Thermo Fisher Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
 Figure 52. Kej Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
 Figure 53. Illumina Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
 Figure 54. Bio Mérieux Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
 Figure 55. Bio-Rad Life Medicine Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
 Figure 56. Agilent Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
 Figure 57. Daan Gene Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
 Figure 58. Ed Bio Revenue Growth Rate in Colorectal Cancer Molecular Diagnostics Kit Business (2020-2025)
 Figure 59. Bottom-up and Top-down Approaches for This Report
 Figure 60. Data Triangulation
 Figure 61. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS